Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California. The event brings together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology as part of Octane's Innovation Event Series. The forum will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape.
The event includes innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster partnerships and accelerate development of next-generation neurotechnology solutions. Octane fosters a future-focused ecosystem of tech and medtech companies across Southern California by connecting people, resources, and capital. The organization's mission is to drive innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the growth and development of Southern California's tech and medtech industries. More information about Octane's work is available at https://www.octaneoc.org.
The Neuro Tech Forum represents a significant gathering for an industry that is rapidly evolving with advancements in brain-computer interfaces, neuroprosthetics, and digital therapeutics. By bringing together diverse stakeholders including clinicians who understand clinical needs, entrepreneurs developing new technologies, and investors who can provide necessary funding, the event creates a unique environment for cross-pollination of ideas and formation of strategic partnerships. Neurotechnology has emerged as one of the most promising frontiers in medical technology, with applications ranging from treating neurological disorders to enhancing human capabilities.
The timing of this forum in 2026 positions it at a critical juncture as many neurotech innovations are moving from research laboratories to clinical applications and commercial markets. The inclusion of investment-focused sessions acknowledges the importance of capital in translating scientific discoveries into viable products and therapies that can reach patients. The event's location in Southern California is strategic, as the region has become a hub for both technology and medical innovation. By hosting the forum in Newport Beach, Octane leverages Southern California's concentration of research institutions, medical centers, technology companies, and investment firms interested in the neurotechnology space.
The networking opportunities built into the forum schedule are designed to facilitate connections that might otherwise take months or years to develop organically. This gathering matters because neurotechnology represents a transformative field with potential to address some of humanity's most challenging medical conditions while pushing the boundaries of human-machine interaction. The forum's structured approach to connecting clinical expertise with entrepreneurial innovation and investment capital creates a powerful catalyst for accelerating neurotech solutions from concept to reality. As the industry approaches commercialization milestones for many technologies, events like this become increasingly important for aligning stakeholders and overcoming barriers to implementation.
